Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2025-02-07 00:00:00 ET · period of report 2025-02-06 · accession 0001628280-25-004478 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-07 | 2025-02-06 | ARWR | INGRAM DOUGLAS S | Dir | A - Grant | $20.09 | +38.4K | 38.4K | New | +$771.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-06 | A | A | 38,396 | $20.09 | 38,396 | D | — | — | (F1) Represents shares underlying restricted stock units with a grant date 02/06/2025, which will vest in three years. |